D

Duopharma Biotech Bhd
KLSE:DPHARMA

Watchlist Manager
Duopharma Biotech Bhd
KLSE:DPHARMA
Watchlist
Price: 1.24 MYR -1.59%
Market Cap: 1.2B MYR
Have any thoughts about
Duopharma Biotech Bhd?
Write Note

Duopharma Biotech Bhd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Duopharma Biotech Bhd
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
D
Duopharma Biotech Bhd
KLSE:DPHARMA
Revenue
myr787.5m
CAGR 3-Years
8%
CAGR 5-Years
7%
CAGR 10-Years
16%
P
PeterLabs Holdings Bhd
KLSE:PLABS
Revenue
myr176.9m
CAGR 3-Years
3%
CAGR 5-Years
13%
CAGR 10-Years
13%
A
Apex Healthcare Bhd
KLSE:AHEALTH
Revenue
myr964.3m
CAGR 3-Years
9%
CAGR 5-Years
7%
CAGR 10-Years
7%
R
Rhone Ma Holdings Bhd
KLSE:RHONEMA
Revenue
myr217.4m
CAGR 3-Years
11%
CAGR 5-Years
12%
CAGR 10-Years
N/A
Y
YSP Southeast Asia Holding Bhd
KLSE:YSPSAH
Revenue
myr364.5m
CAGR 3-Years
9%
CAGR 5-Years
4%
CAGR 10-Years
7%
K
Kotra Industries Bhd
KLSE:KOTRA
Revenue
myr238.8m
CAGR 3-Years
11%
CAGR 5-Years
8%
CAGR 10-Years
5%
No Stocks Found

Duopharma Biotech Bhd
Glance View

Market Cap
1.2B MYR
Industry
Pharmaceuticals

Duopharma Biotech Bhd.is an investment holding company, which engages in the manufacturing and distribution of pharmaceutical products. The company is headquartered in Klang, Selangor. The company went IPO on 2002-07-18. The Company, through its subsidiaries is engaged in manufacturing, distribution, importing and exporting of pharmaceutical products and medicines. The firm also engaged in research and development of pharmaceutical products. Its subsidiaries include Duopharma (M) Sendirian Berhad, Duopharma Manufacturing (Bangi) Sdn. Bhd., Duopharma Marketing Sdn. Bhd., Duopharma Consumer Healthcare Sdn. Bhd., Duopharma HAPI Sdn. Bhd., Duopharma Innovation Sdn. Bhd., Unique Pharmacy (Penang) Sdn. Bhd., Sentosa Pharmacy Sdn. Bhd., Duopharma Manufacturing (Glenmarie) Sdn. Bhd., Negeri Pharmacy Sdn. Bhd., Duopharma (Singapore) Pte. Ltd. and DB (Philippines), Inc.

DPHARMA Intrinsic Value
1.69 MYR
Undervaluation 27%
Intrinsic Value
Price
D

See Also

What is Duopharma Biotech Bhd's Revenue?
Revenue
787.5m MYR

Based on the financial report for Sep 30, 2024, Duopharma Biotech Bhd's Revenue amounts to 787.5m MYR.

What is Duopharma Biotech Bhd's Revenue growth rate?
Revenue CAGR 10Y
16%

Over the last year, the Revenue growth was 14%. The average annual Revenue growth rates for Duopharma Biotech Bhd have been 8% over the past three years , 7% over the past five years , and 16% over the past ten years .

Back to Top